Categories: Insider Trading News

Tempus AI CEO Eric Lefkofsky sells $7 million in shares


Eric Lefkofsky, CEO and Chairman of Tempus AI, Inc. (NASDAQ:TEM), not too long ago bought shares price roughly $7,045,334, in response to an SEC submitting. The transactions occurred on December 18, 2024, with the sale costs starting from $37.34 to $39.38 per share. The sale comes because the inventory has skilled a major 13% decline over the previous week, in response to InvestingPro information. Following these transactions, Lefkofsky retains important holdings within the firm by way of varied entities, together with Blue Media, LLC and Grey Media, LLC. The gross sales have been made beneath a pre-established buying and selling plan. The $5.2 billion market cap firm presently trades close to its InvestingPro Honest Worth, sustaining a strong liquidity place with a present ratio of two.69 and exhibiting robust income development of 32% year-over-year. InvestingPro subscribers can entry 6 extra key insights about Tempus AI’s monetary well being and market place.

In different current information, Tempus AI has skilled important adjustments in its inventory worth targets following its newest earnings report and strategic acquisition of genetics agency Ambry. Piper Sandler raised its worth goal from $40 to $70, sustaining a Impartial ranking. Stifel downgraded the inventory from Purchase to Maintain, however elevated the worth goal to $65. Needham raised its inventory worth goal to $56, holding its Purchase ranking.

Tempus AI’s acquisition of Ambry Genetics is considered as a key strategic transfer, doubtlessly providing rapid genomics capabilities and future alternatives in information and purposes. The corporate has additionally partnered with Avacta Therapeutics to advance oncology drug growth utilizing AI, granting Avacta entry to Tempus’s complete multimodal datasets.

Additional, Tempus AI’s Tempus ECG-AF machine, which makes use of synthetic intelligence to determine sufferers at larger danger of atrial fibrillation/flutter, not too long ago obtained FDA clearance. These are among the many current developments surrounding Tempus AI.

This text was generated with the help of AI and reviewed by an editor. For extra info see our T&C.

admin

Share
Published by
admin

Recent Posts

Mexico fund CEO Alberto Osorio buys $203k in widespread inventory

Alberto Osorio, President and CEO of Mexico Fund Inc. (NYSE:MXF), lately bought 15,000 shares of…

57 seconds ago

Fifth Third Bancorp’s SWOT evaluation: inventory outlook amid shifting monetary panorama

Fifth Third Bancorp (NASDAQ:FITB), a outstanding participant within the U.S. banking sector with a market…

16 minutes ago

ECB’s Rehn says inflation confidence will enable for charge cuts

FRANKFURT (Reuters) - European Central Financial institution rates of interest will maintain falling as policymakers…

21 minutes ago

Seven indicted in largest COVID-19 tax fraud case

On Wednesday, an indictment was unsealed in Central Islip, New York, revealing expenses in opposition…

36 minutes ago

Unique-Bangladesh’s excessive development beneath ousted PM Hasina was ‘faux’, interim head Yunus says

By Una Galani and Peter Thal Larsen DAVOS, Switzerland (Reuters) - The pinnacle of Bangladesh's…

41 minutes ago

Retail Bitcoin Traders Get Energetic, 25,000 BTC Stacked in One Month

U.At this time - The previous month has seen retail Bitcoin (BTC) traders growing their…

46 minutes ago